About the News Conference
Leading national infectious disease experts presented final influenza (flu) vaccine coverage data from the 2021-2022 US flu season and discussed the importance of vaccination against flu and pneumococcal disease, particularly among older adults and those with chronic health conditions who are at higher risk for related complications.
Results from a new NFID national survey of US adults were also shared on vaccination attitudes and behaviors, including the impacts of the COVID-19 pandemic, at the 2022 National Foundation for Infectious Diseases (NFID) Influenza/Pneumococcal Disease News Conference on Tuesday, October 4, 2022.
Panelists included: Tamika C. Auguste, MD, ACOG Fellow and Chair, Women’s and Infants’ Services, MedStar Washington Hospital Center; William Schaffner, MD, NFID Medical Director; Patricia (Patsy) A. Stinchfield, RN, MS, CPNP, NFID President (Moderator); Jeb S. Teichman, MD, Retired Pediatrician and Healthcare Executive; and Rochelle P. Walensky, MD, MPH, Centers for Disease Control and Prevention (CDC) Director, with additional expert Alicia M. Fry, MD, MPH, Chief, Epidemiology and Prevention Branch, Influenza Division, CDC.
Press Kit Information
View the conference press release, agenda, panelist bios, as well as related resources below.
Kaitlyn’s Story (Flu)
Kaitlyn was a student at the University of Florida in Gainesville when she nearly died from flu
Respiratory Immunization Graphics
Graphics and sample social posts to help raise awareness about preventing COVID-19, flu, RSV, and pneumococcal disease
What Is an Antiviral?
Overview of antivirals—what they are, how they work, and what diseases they help treat
Leading By Example
National initiative calling on community leaders to lead by example by making a commitment to disease prevention
2022 National Survey: Attitudes about Influenza and Pneumococcal Disease, and the Impacts of COVID-19
NFID 2022 National Survey on flu and pneumococcal disease in the context of COVID-19
